129 related articles for article (PubMed ID: 18467244)
41. Dissemination of the rmtB gene carried on IncF and IncN plasmids among Enterobacteriaceae in a pig farm and its environment.
Yao Q; Zeng Z; Hou J; Deng Y; He L; Tian W; Zheng H; Chen Z; Liu JH
J Antimicrob Chemother; 2011 Nov; 66(11):2475-9. PubMed ID: 21852287
[TBL] [Abstract][Full Text] [Related]
42. Investigation of mutation distribution in DNA gyrase and topoisomerase IV genes in ciprofloxacin-non-susceptible Enterobacteriaceae isolated from blood cultures in a tertiary care university hospital in South Korea, 2005-2010.
Nam YS; Cho SY; Yang HY; Park KS; Jang JH; Kim YT; Jeong JW; Suh JT; Lee HJ
Int J Antimicrob Agents; 2013 Feb; 41(2):126-9. PubMed ID: 23265914
[TBL] [Abstract][Full Text] [Related]
43. [Prevalence of qnr genes in clinical Enterobacteriaceae non-susceptible to fluoroquinolone in Poland].
Piekarska K; Rzeczkowska M; Zacharczuk K; Chróst A; Januszkiewicz A; Bareja E; Olak M; Gierczyński R
Med Dosw Mikrobiol; 2012; 64(3):211-9. PubMed ID: 23285775
[TBL] [Abstract][Full Text] [Related]
44. Prevalence of quinolone resistance determinant qnrA6 among broad- and extended-spectrum beta-lactam-resistant Proteus mirabilis and Morganella morganii clinical isolates with sul1-type class 1 integron association in a Tunisian Hospital.
Mahrouki S; Perilli M; Bourouis A; Chihi H; Ferjani M; Ben Moussa M; Amicosante G; Belhadj O
Scand J Infect Dis; 2013 Aug; 45(8):600-5. PubMed ID: 23746343
[TBL] [Abstract][Full Text] [Related]
45. Survival in the environment is a possible key factor for the expansion of Escherichia coli strains producing extended-spectrum β-lactamases.
Starlander G; Yin H; Edquist P; Melhus Å
APMIS; 2014 Jan; 122(1):59-67. PubMed ID: 23755901
[TBL] [Abstract][Full Text] [Related]
46. Beta-lactamase-producing Enterobacteriaceae in hospital effluents.
Korzeniewska E; Harnisz M
J Environ Manage; 2013 Jul; 123():1-7. PubMed ID: 23563146
[TBL] [Abstract][Full Text] [Related]
47. Expansion of ESBL-producing Klebsiella pneumoniae in hospitalized patients: a successful story of international clones (ST15, ST147, ST336) and epidemic plasmids (IncR, IncFIIK).
Rodrigues C; Machado E; Ramos H; Peixe L; Novais Â
Int J Med Microbiol; 2014 Nov; 304(8):1100-8. PubMed ID: 25190354
[TBL] [Abstract][Full Text] [Related]
48. In vitro activity of rifaximin, a topical rifamycin derivative, against Chlamydia trachomatis.
Prasad ES; Wenman WM
Diagn Microbiol Infect Dis; 1993 Feb; 16(2):135-6. PubMed ID: 8467625
[TBL] [Abstract][Full Text] [Related]
49. First characterisation of plasmid-mediated quinolone resistance-qnrS1 co-expressed bla CTX-M-15 and bla DHA-1 genes in clinical strain of Morganella morganii recovered from a Tunisian Intensive Care Unit.
Mahrouki S; Bourouis A; Chihi H; Ouertani R; Ferjani M; Moussa MB; Barguellil F; Belhadj O
Indian J Med Microbiol; 2012; 30(4):437-41. PubMed ID: 23183469
[TBL] [Abstract][Full Text] [Related]
50. Prevalence of acquired fosfomycin resistance among extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Korea and IS26-composite transposon surrounding fosA3.
Lee SY; Park YJ; Yu JK; Jung S; Kim Y; Jeong SH; Arakawa Y
J Antimicrob Chemother; 2012 Dec; 67(12):2843-7. PubMed ID: 22893681
[TBL] [Abstract][Full Text] [Related]
51. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M
Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
[TBL] [Abstract][Full Text] [Related]
52. Evidence of in vivo transfer of a plasmid encoding the extended-spectrum beta-lactamase TEM-24 and other resistance factors among different members of the family Enterobacteriaceae.
Neuwirth C; Siebor E; Pechinot A; Duez JM; Pruneaux M; Garel F; Kazmierczak A; Labia R
J Clin Microbiol; 2001 May; 39(5):1985-8. PubMed ID: 11326030
[TBL] [Abstract][Full Text] [Related]
53. [Investigation of plasmid-mediated quinolone resistance determinants in Enterobacteriaceae: a multicenter study].
Coban AY; Nohut OK; Tanrıverdi Çaycı Y; Bayramoğlu G; Pirinççiler M; Cetinkaya E; Cekiç Cihan C; Bozdoğan B; Durupınar B
Mikrobiyol Bul; 2012 Jul; 46(3):366-74. PubMed ID: 22951649
[TBL] [Abstract][Full Text] [Related]
54. Eubiotic properties of rifaximin: Disruption of the traditional concepts in gut microbiota modulation.
Ponziani FR; Zocco MA; D'Aversa F; Pompili M; Gasbarrini A
World J Gastroenterol; 2017 Jul; 23(25):4491-4499. PubMed ID: 28740337
[TBL] [Abstract][Full Text] [Related]
55. Bile acids improve the antimicrobial effect of rifaximin.
Darkoh C; Lichtenberger LM; Ajami N; Dial EJ; Jiang ZD; DuPont HL
Antimicrob Agents Chemother; 2010 Sep; 54(9):3618-24. PubMed ID: 20547807
[TBL] [Abstract][Full Text] [Related]
56. Effects of rifaximin administration on the intestinal microbiota in patients with ulcerative colitis.
Brigidi P; Swennen E; Rizzello F; Bozzolasco M; Matteuzzi D
J Chemother; 2002 Jun; 14(3):290-5. PubMed ID: 12120885
[TBL] [Abstract][Full Text] [Related]
57. The potential for development of clinically relevant microbial resistance to rifaximin-α: a narrative review.
DuPont HL
Clin Microbiol Rev; 2023 Dec; 36(4):e0003923. PubMed ID: 37971270
[TBL] [Abstract][Full Text] [Related]
58. Rifaximin: An Antibiotic with Important Biologic Effects.
DuPont HL
Mini Rev Med Chem; 2015; 16(3):200-5. PubMed ID: 26202192
[TBL] [Abstract][Full Text] [Related]
59. Emergence of rifampin-resistant staphylococci after rifaximin administration in cirrhotic patients.
Chang JY; Kim SE; Kim TH; Woo SY; Ryu MS; Joo YH; Lee KE; Lee J; Lee KH; Moon CM; Jung HK; Shim KN; Jung SA
PLoS One; 2017; 12(10):e0186120. PubMed ID: 28982166
[TBL] [Abstract][Full Text] [Related]
60. The Possible Innovative Use of Bifidobacterium longum W11 in Association With Rifaximin: A New Horizon for Combined Approach?
Graziano T; Amoruso A; Nicola S; Deidda F; Allesina S; Pane M; Piffanelli P; Strozzi F; Mogna L; Del Piano M
J Clin Gastroenterol; 2016; 50 Suppl 2, Proceedings from the 8th Probiotics, Prebiotics & New Foods for Microbiota and Human Health meeting held in Rome, Italy on September 13-15, 2015():S153-S156. PubMed ID: 27741162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
